Parallel Advisors’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108 | Hold |
50
| – | – | ﹤0.01% | 3431 |
|
|
2025
Q1 | $219 | Hold |
50
| – | – | ﹤0.01% | 3353 |
|
|
2024
Q4 | $234 | Hold |
50
| – | – | ﹤0.01% | 3331 |
|
|
2024
Q3 | $351 | Hold |
50
| – | – | ﹤0.01% | 3209 |
|
|
2024
Q2 | $343 | Hold |
50
| – | – | ﹤0.01% | 3126 |
|
|
2024
Q1 | $707 | Hold |
50
| – | – | ﹤0.01% | 2996 |
|
|
2023
Q4 | $376 | Sell |
50
-50
| -50% | -$376 | ﹤0.01% | 3099 |
|
|
2023
Q3 | $1.5K | Hold |
100
| – | – | ﹤0.01% | 2892 |
|
|
2023
Q2 | $1.59K | Hold |
100
| – | – | ﹤0.01% | 2818 |
|
|
2023
Q1 | $717 | Hold |
100
| – | – | ﹤0.01% | 3026 |
|
|
2022
Q4 | $580 | Hold |
100
| – | – | ﹤0.01% | 3008 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 2806 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 2668 |
|
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 2660 |
|
|
2021
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 2637 |
|
|
2021
Q3 | $2K | Sell |
100
-2,411
| -96% | -$48.2K | ﹤0.01% | 2614 |
|
|
2021
Q2 | $88K | Buy |
2,511
+27
| +1% | +$946 | ﹤0.01% | 976 |
|
|
2021
Q1 | $245K | Sell |
2,484
-2,383
| -49% | -$235K | 0.01% | 566 |
|
|
2020
Q4 | $528K | Hold |
4,867
| – | – | 0.03% | 317 |
|
|
2020
Q3 | $501K | Buy |
4,867
+96
| +2% | +$9.88K | 0.03% | 304 |
|
|
2020
Q2 | $996K | Sell |
4,771
-995
| -17% | -$208K | 0.07% | 177 |
|
|
2020
Q1 | $563K | Buy |
+5,766
| New | +$563K | 0.05% | 222 |
|